Using the CO2 laser in oculoplastic surgery

Article

Over the past five years, we have successfully performed oculoplastic surgery on several hundred patients at the Belgian Ocular Laser Center (BOLC; www.BOLC.org) in Ghent, Belgium and, during this time, I have found the CO2 laser to provide an excellent alternative to the scalpel for treating the eyelids. Finally, we can offer bloodless surgery and improved outcomes.

Over the past five years, we have successfully performed oculoplastic surgery on several hundred patients at the Belgian Ocular Laser Center (BOLC; http://www.BOLC.org/) in Ghent, Belgium and, during this time, I have found the CO2 laser to provide an excellent alternative to the scalpel for treating the eyelids. Finally, we can offer bloodless surgery and improved outcomes.

The major indications for this laser include blepharoplasty, entropion, ectropion, ptosis of the upper eyelid and xanthelasmata. We do not, however, use this type of laser for skin resurfacing because we strongly believe that the Erbium:YAG laser is a better and safer option for superficial skin tissue ablation.

Understanding the physics

Laser energy is a single wavelength and the CO2 laser, which is at a wavelength of 10,600 nm, is strongly absorbed by water (a chromophore). The CO2 laser is an infrared laser and, as such, can only be delivered through an articulated arm. It is important to note, however, that if the aiming beam is coaxial in nature, one must ensure that this beam and the infrared beam are exactly aligned, by testing the laser on a tongue blade prior to surgery.

What do you need to get started?

We currently use the Coherent UltraPulse CO2 laser (Lumenis), the ultrapulse mode of which is characterized by pulses of high peak power, delivered in rapid sequence, which are sustained over the entire duration of the pulse. This modality is used to make the skin incision. The constant wave modality, on the other hand, produces continuously applied light with no variation over time, to incise conjunctiva and to dissect tissue.

Certain safety issues must be taken into consideration when performing this procedure and it is imperative that a notice, advising that laser surgery is in progress, is posted outside of the surgical suite in order to eliminate the chance of being disturbed.

surgical field.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.